FIRMAGON DIN 02337037
Status: Marketed
Holder: FERRING INC
Available to quote
Health Canada record
| Active ingredient(s) | DEGARELIX (DEGARELIX ACETATE) 120 MG |
|---|
| Dosage form | Powder For Solution |
|---|
| Route | Subcutaneous |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | L02BX02 DEGARELIX |
|---|
| Original market date | 24-Nov-2009 |
|---|
| Current status date | 24-Nov-2009 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Ferring Inc. — licence 100274, currently licensed, last inspection rating C (2026-05-19).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DEGARELIX (DEGARELIX ACETATE)
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02337029 | FIRMAGON | FERRING INC | Powder For Solution | DEGARELIX (DEGARELIX ACETATE) 80 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 10784 | 2009-11-16 | New Drug Submission (NDS) | |
Request a quote for FIRMAGON
How to read a Canadian DIN record